1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Acute Erythroid Leukemia: new trials by email Literature Review of Acute Erythroid Leukemia trials Research Report on Acute Erythroid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia Azacitidine, Laboratory Biomarker Analysis, Pharmacological Study - Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 135 | 2006-11-22 | 2026-08-07 |
Anemia, Refractory (1) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Erythroblastic, Acute (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic Syndromes (1)
Anemia (1) · Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Myelodysplastic-Myeloproliferative Diseases (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Azacitidine (1) · Vorinostat (1)
National Cancer Institute (NCI) (1)
United States (1)
N01CM17103 (1), N01CM62204 (1), P30CA013330 (1)